BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 31838085)

  • 21. The cyclophilin D/Drp1 axis regulates mitochondrial fission contributing to oxidative stress-induced mitochondrial dysfunctions in SH-SY5Y cells.
    Xiao A; Gan X; Chen R; Ren Y; Yu H; You C
    Biochem Biophys Res Commun; 2017 Jan; 483(1):765-771. PubMed ID: 27993675
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Lipocalin 2 over-expression facilitates progress of castration-resistant prostate cancer via improving androgen receptor transcriptional activity.
    Ding G; Wang J; Feng C; Jiang H; Xu J; Ding Q
    Oncotarget; 2016 Sep; 7(39):64309-64317. PubMed ID: 27602760
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aβ-Induced Drp1 phosphorylation through Akt activation promotes excessive mitochondrial fission leading to neuronal apoptosis.
    Kim DI; Lee KH; Gabr AA; Choi GE; Kim JS; Ko SH; Han HJ
    Biochim Biophys Acta; 2016 Nov; 1863(11):2820-2834. PubMed ID: 27599716
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeting androgen receptor versus targeting androgens to suppress castration resistant prostate cancer.
    Guo C; Yeh S; Niu Y; Li G; Zheng J; Li L; Chang C
    Cancer Lett; 2017 Jul; 397():133-143. PubMed ID: 28323036
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Drp1-Mediated Mitochondrial Metabolic Dysfunction Inhibits the Tumor Growth of Pituitary Adenomas.
    Fan K; Ding X; Zang Z; Zhang Y; Tang X; Pei X; Chen Q; Yin H; Zheng X; Chen Y; Li S; Yang H
    Oxid Med Cell Longev; 2022; 2022():5652586. PubMed ID: 35368865
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mitochondrial division inhibitor (mdivi-1) decreases oxidative metabolism in cancer.
    Dai W; Wang G; Chwa J; Oh ME; Abeywardana T; Yang Y; Wang QA; Jiang L
    Br J Cancer; 2020 Apr; 122(9):1288-1297. PubMed ID: 32147668
    [TBL] [Abstract][Full Text] [Related]  

  • 27. SOCS2 mediates the cross talk between androgen and growth hormone signaling in prostate cancer.
    Iglesias-Gato D; Chuan YC; Wikström P; Augsten S; Jiang N; Niu Y; Seipel A; Danneman D; Vermeij M; Fernandez-Perez L; Jenster G; Egevad L; Norstedt G; Flores-Morales A
    Carcinogenesis; 2014 Jan; 35(1):24-33. PubMed ID: 24031028
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A hnRNP K⁻AR-Related Signature Reflects Progression toward Castration-Resistant Prostate Cancer.
    Capaia M; Granata I; Guarracino M; Petretto A; Inglese E; Cattrini C; Ferrari N; Boccardo F; Barboro P
    Int J Mol Sci; 2018 Jun; 19(7):. PubMed ID: 29966326
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacological activation of AMPK prevents Drp1-mediated mitochondrial fission and alleviates endoplasmic reticulum stress-associated endothelial dysfunction.
    Li J; Wang Y; Wang Y; Wen X; Ma XN; Chen W; Huang F; Kou J; Qi LW; Liu B; Liu K
    J Mol Cell Cardiol; 2015 Sep; 86():62-74. PubMed ID: 26196303
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Adaptive phenotype drives resistance to androgen deprivation therapy in prostate cancer.
    Ferrari N; Granata I; Capaia M; Piccirillo M; Guarracino MR; Venè R; Brizzolara A; Petretto A; Inglese E; Morini M; Astigiano S; Amaro AA; Boccardo F; Balbi C; Barboro P
    Cell Commun Signal; 2017 Dec; 15(1):51. PubMed ID: 29216878
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Checkpoint Kinase 2 Negatively Regulates Androgen Sensitivity and Prostate Cancer Cell Growth.
    Ta HQ; Ivey ML; Frierson HF; Conaway MR; Dziegielewski J; Larner JM; Gioeli D
    Cancer Res; 2015 Dec; 75(23):5093-105. PubMed ID: 26573794
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mitochondrial localization, import, and mitochondrial function of the androgen receptor.
    Bajpai P; Koc E; Sonpavde G; Singh R; Singh KK
    J Biol Chem; 2019 Apr; 294(16):6621-6634. PubMed ID: 30792308
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LncRNA HOTAIR Enhances the Androgen-Receptor-Mediated Transcriptional Program and Drives Castration-Resistant Prostate Cancer.
    Zhang A; Zhao JC; Kim J; Fong KW; Yang YA; Chakravarti D; Mo YY; Yu J
    Cell Rep; 2015 Oct; 13(1):209-221. PubMed ID: 26411689
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Drp1 is dispensable for mitochondria biogenesis in induction to pluripotency but required for differentiation of embryonic stem cells.
    Wang L; Ye X; Zhao Q; Zhou Z; Dan J; Zhu Y; Chen Q; Liu L
    Stem Cells Dev; 2014 Oct; 23(20):2422-34. PubMed ID: 24937776
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of AKAP1 triggers Drp1 dephosphorylation-mediated mitochondrial fission and loss in retinal ganglion cells.
    Edwards G; Perkins GA; Kim KY; Kong Y; Lee Y; Choi SH; Liu Y; Skowronska-Krawczyk D; Weinreb RN; Zangwill L; Strack S; Ju WK
    Cell Death Dis; 2020 Apr; 11(4):254. PubMed ID: 32312949
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Androgens induce a distinct response of epithelial-mesenchymal transition factors in human prostate cancer cells.
    Colditz J; Rupf B; Maiwald C; Baniahmad A
    Mol Cell Biochem; 2016 Oct; 421(1-2):139-47. PubMed ID: 27562825
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Targeting Oct1 genomic function inhibits androgen receptor signaling and castration-resistant prostate cancer growth.
    Obinata D; Takayama K; Fujiwara K; Suzuki T; Tsutsumi S; Fukuda N; Nagase H; Fujimura T; Urano T; Homma Y; Aburatani H; Takahashi S; Inoue S
    Oncogene; 2016 Dec; 35(49):6350-6358. PubMed ID: 27270436
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Estrogen induces androgen-repressed SOX4 expression to promote progression of prostate cancer cells.
    Yang M; Wang J; Wang L; Shen C; Su B; Qi M; Hu J; Gao W; Tan W; Han B
    Prostate; 2015 Sep; 75(13):1363-75. PubMed ID: 26015225
    [TBL] [Abstract][Full Text] [Related]  

  • 39. DRP1 inhibition rescues retinal ganglion cells and their axons by preserving mitochondrial integrity in a mouse model of glaucoma.
    Kim KY; Perkins GA; Shim MS; Bushong E; Alcasid N; Ju S; Ellisman MH; Weinreb RN; Ju WK
    Cell Death Dis; 2015 Aug; 6(8):e1839. PubMed ID: 26247724
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Androgen receptor (AR) degradation enhancer ASC-J9
    Cheng MA; Chou FJ; Wang K; Yang R; Ding J; Zhang Q; Li G; Yeh S; Xu D; Chang C
    Cancer Lett; 2018 Mar; 417():182-191. PubMed ID: 29203251
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.